{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T13:28:18Z","timestamp":1745414898623},"reference-count":78,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,8]]},"DOI":"10.7759\/cureus.64074","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T12:30:51Z","timestamp":1720441851000},"source":"Crossref","is-referenced-by-count":1,"title":["The Genetic Diagnostics of Hemochromatosis: Disparities in Low- Versus High-Income Countries"],"prefix":"10.7759","author":[{"given":"Sol","family":"Villa Nogueyra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda F","family":"Trujillo Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda L","family":"Garcia Oliva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Vidal-Gallardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Ram\u00edrez Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Beltran Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andres Manuel","family":"Vargas Beltran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 D","family":"Guillen Sandoval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Arriaga Escamilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marily","family":"Martinez Ramirez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.03.033","article-title":"EASL Clinical Practice Guidelines on haemochromatosis","volume":"77","year":"2022","unstructured":"EASL Clinical Practice Guidelines on haemochromatosis. J Hepatol. 2022, 77.479-502. 10.1016\/j.jhep.2022.03.033","journal-title":"J Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S1665-2681(19)32046-0","article-title":"Hereditary hemochromatosis: genetics, pathogenesis, and clinical management","volume":"4","author":"Alexander J","year":"2005","unstructured":"Alexander J, Kowdley KV. Hereditary hemochromatosis: genetics, pathogenesis, and clinical management. Ann Hepatol. 2005, 4:240-7. 10.1016\/S1665-2681(19)32046-0","journal-title":"Ann Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2119758","article-title":"Hemochromatosis","volume":"387","author":"Olynyk JK","year":"2022","unstructured":"Olynyk JK, Ramm GA. Hemochromatosis. N Engl J Med. 2022, 387:2159-70. 10.1056\/NEJMra2119758","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s41669-023-00463-6","article-title":"Health economic evaluations of hemochromatosis screening and treatment: a systematic review","volume":"8","author":"Hoxha M","year":"2024","unstructured":"Hoxha M, Malaj V, Zappacosta B. Health economic evaluations of hemochromatosis screening and treatment: a systematic review. Pharmacoecon Open. 2024, 8:147-70. 10.1007\/s41669-023-00463-6","journal-title":"Pharmacoecon Open"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199106000-00013","article-title":"Biochemical liver profile in hemochromatosis. A survey of 100 patients","volume":"13","author":"Lin E","year":"1991","unstructured":"Lin E, Adams PC. Biochemical liver profile in hemochromatosis. A survey of 100 patients. J Clin Gastroenterol. 1991, 13:316-20. 10.1097\/00004836-199106000-00013","journal-title":"J Clin Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD.V92.8.2979","article-title":"Juvenile genetic hemochromatosis is clinically and genetically distinct from the classical HLA-related disorder","volume":"92","author":"Cazzola M","year":"1998","unstructured":"Cazzola M, Cerani P, Rovati A, Iannone A, Claudiani G, Bergamaschi G. Juvenile genetic hemochromatosis is clinically and genetically distinct from the classical HLA-related disorder. Blood. 1998, 92:2979-81. 10.1182\/BLOOD.V92.8.2979","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.8381548","article-title":"Signal transduction: from the molecular to the functional (Book in Spanish)","author":"Sampieri-Cabrera R","year":"2023","unstructured":"Sampieri-Cabrera R, Calder\u00f3n-Mart\u00ednez E. Signal transduction: from the molecular to the functional (Book in Spanish). UNAM, Mexico City, Mexico; 2023. 10.5281\/zenodo.8381548"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddg225","article-title":"Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis","volume":"12","author":"Merryweather-Clarke AT","year":"2003","unstructured":"Merryweather-Clarke AT, Cadet E, Bomford A, et al.. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis. Hum Mol Genet. 2003, 12:2241-7. 10.1093\/hmg\/ddg225","journal-title":"Hum Mol Genet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-005-0069-y","article-title":"Non-HFE hemochromatosis: genetics, pathogenesis, and clinical management","volume":"7","author":"Nelson JE","year":"2005","unstructured":"Nelson JE, Kowdley KV. Non-HFE hemochromatosis: genetics, pathogenesis, and clinical management. Curr Gastroenterol Rep. 2005, 7:71-80. 10.1007\/s11894-005-0069-y","journal-title":"Curr Gastroenterol Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0503804102","article-title":"The molecular basis of ferroportin-linked hemochromatosis","volume":"102","author":"De Domenico I","year":"2005","unstructured":"De Domenico I, Ward DM, Nemeth E, Vaughn MB, Musci G, Ganz T, Kaplan J. The molecular basis of ferroportin-linked hemochromatosis. Proc Natl Acad Sci U S A. 2005, 102:8955-60. 10.1073\/pnas.0503804102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s1079-9796(03)00165-7","article-title":"Ferroportin 1 (SCL40A1) variant associated with iron overload in African-Americans","volume":"31","author":"Beutler E","year":"2003","unstructured":"Beutler E, Barton JC, Felitti VJ, et al.. Ferroportin 1 (SCL40A1) variant associated with iron overload in African-Americans. Blood Cells Mol Dis. 2003, 31:305-9. 10.1016\/s1079-9796(03)00165-7","journal-title":"Blood Cells Mol Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.39436","article-title":"Aminotransferases in relation to the severity of dengue: a systematic review","volume":"15","author":"Kalluru PK","year":"2023","unstructured":"Kalluru PK, Mamilla M, Valisekka SS, et al.. Aminotransferases in relation to the severity of dengue: a systematic review. Cureus. 2023, 15:e39436. 10.7759\/cureus.39436","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/907356","article-title":"Clinical manifestations of hemochromatosis in HFE C282Y homozygotes identified by screening","volume":"22","author":"McLaren GD","year":"2008","unstructured":"McLaren GD, McLaren CE, Adams PC, et al.. Clinical manifestations of hemochromatosis in HFE C282Y homozygotes identified by screening. Can J Gastroenterol. 2008, 22:923-30. 10.1155\/2008\/907356","journal-title":"Can J Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2014.09.011","article-title":"Diagnosis and management of hereditary hemochromatosis","volume":"19","author":"Salgia RJ","year":"2015","unstructured":"Salgia RJ, Brown K. Diagnosis and management of hereditary hemochromatosis. Clin Liver Dis. 2015, 19:187-98. 10.1016\/j.cld.2014.09.011","journal-title":"Clin Liver Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/J.HOC.2014.04.006","article-title":"Diagnostic evaluation of hereditary hemochromatosis (HFE and non-HFE)","volume":"28","author":"Bardou-Jacquet E","year":"2014","unstructured":"Bardou-Jacquet E, Brissot P. Diagnostic evaluation of hereditary hemochromatosis (HFE and non-HFE). Hematol Oncol Clin North Am. 2014, 28:625-35. 10.1016\/J.HOC.2014.04.006","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2014.04.006","article-title":"Diagnostic evaluation of hereditary hemochromatosis (HFE and non-HFE)","volume":"28","author":"Bardou-Jacquet E","year":"2014","unstructured":"Bardou-Jacquet E, Brissot P. Diagnostic evaluation of hereditary hemochromatosis (HFE and non-HFE). Hematol Oncol Clin North Am. 2014, 28:625-35. 10.1016\/j.hoc.2014.04.006","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021011338","article-title":"Hemochromatosis classification: update and recommendations by the BIOIRON Society","volume":"139","author":"Girelli D","year":"2022","unstructured":"Girelli D, Busti F, Brissot P, Cabantchik I, Muckenthaler MU, Porto G. Hemochromatosis classification: update and recommendations by the BIOIRON Society. Blood. 2022, 139:3018-29. 10.1182\/blood.2021011338","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11071279","article-title":"Pathogenesis, diagnosis, and clinical implications of hereditary hemochromatosis-the cardiological point of view","volume":"11","author":"Dani\u0142owicz-Szymanowicz L","year":"2021","unstructured":"Dani\u0142owicz-Szymanowicz L, \u015awi\u0105tczak M, Sikorska K, Starzy\u0144ski RR, Raczak A, Lipi\u0144ski P. Pathogenesis, diagnosis, and clinical implications of hereditary hemochromatosis-the cardiological point of view. Diagnostics (Basel). 2021, 11:24-6. 10.3390\/diagnostics11071279","journal-title":"Diagnostics (Basel)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-129-11_part_2-199812011-00003","article-title":"Management of hemochromatosis. Hemochromatosis Management Working Group","volume":"129","author":"Barton JC","year":"1998","unstructured":"Barton JC, McDonnell SM, Adams PC, et al.. Management of hemochromatosis. Hemochromatosis Management Working Group. Ann Intern Med. 1998, 129:932-9. 10.7326\/0003-4819-129-11_part_2-199812011-00003","journal-title":"Ann Intern Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000315","article-title":"ACG clinical guideline: hereditary hemochromatosis","volume":"114","author":"Kowdley KV","year":"2019","unstructured":"Kowdley KV, Brown KE, Ahn J, Sundaram V. ACG clinical guideline: hereditary hemochromatosis. Am J Gastroenterol. 2019, 114:1202-18. 10.14309\/ajg.0000000000000315","journal-title":"Am J Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1159\/000328039","article-title":"Iron chelation with deferasirox in two patients with HFE hemochromatosis and chronic anemia","volume":"126","author":"Nagler M","year":"2011","unstructured":"Nagler M, Gregor M, Wuillemin WA. Iron chelation with deferasirox in two patients with HFE hemochromatosis and chronic anemia. Acta Haematol. 2011, 126:119-21. 10.1159\/000328039","journal-title":"Acta Haematol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12530","article-title":"Deferasirox in patients with iron overload secondary to hereditary hemochromatosis: results of a 1-yr Phase 2 study","volume":"95","author":"Can\u00e7ado R","year":"2015","unstructured":"Can\u00e7ado R, Melo MR, de Moraes Bastos R, Santos PC, Guerra-Shinohara EM, Chiattone C, Ballas SK. Deferasirox in patients with iron overload secondary to hereditary hemochromatosis: results of a 1-yr Phase 2 study. Eur J Haematol. 2015, 95:545-50. 10.1111\/ejh.12530","journal-title":"Eur J Haematol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23879","article-title":"A phase 1\/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis","volume":"52","author":"Phatak P","year":"2010","unstructured":"Phatak P, Brissot P, Wurster M, et al.. A phase 1\/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis. Hepatology. 2010, 52:1671-779. 10.1002\/hep.23879","journal-title":"Hepatology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2020.100154","article-title":"Systemic iron reduction by venesection alters the gut microbiome in patients with haemochromatosis","volume":"2","author":"Parmanand B","year":"2020","unstructured":"Parmanand B, Watson M, Boland KJ, et al.. Systemic iron reduction by venesection alters the gut microbiome in patients with haemochromatosis. JHEP Rep. 2020, 2:100154. 10.1016\/j.jhepr.2020.100154","journal-title":"JHEP Rep"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s10534-012-9555-5","article-title":"Genetic modification of iron metabolism in mice affects the gut microbiota","volume":"25","author":"Buhnik-Rosenblau K","year":"2012","unstructured":"Buhnik-Rosenblau K, Moshe-Belizowski S, Danin-Poleg Y, Meyron-Holtz EG. Genetic modification of iron metabolism in mice affects the gut microbiota. Biometals. 2012, 25:883-92. 10.1007\/s10534-012-9555-5","journal-title":"Biometals"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v15.i8.939","article-title":"Liver transplant in primary sclerosing cholangitis: current trends and future directions","volume":"15","author":"Shah YR","year":"2023","unstructured":"Shah YR, Nombera-Aznaran N, Guevara-Lazo D, et al.. Liver transplant in primary sclerosing cholangitis: current trends and future directions. World J Hepatol. 2023, 15:939-53. 10.4254\/wjh.v15.i8.939","journal-title":"World J Hepatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/czw022","article-title":"Use of traditional medicine in middle-income countries: a WHO-SAGE study","volume":"31","author":"Oyebode O","year":"2016","unstructured":"Oyebode O, Kandala NB, Chilton PJ, Lilford RJ. Use of traditional medicine in middle-income countries: a WHO-SAGE study. Health Policy Plan. 2016, 31:984-91. 10.1093\/heapol\/czw022","journal-title":"Health Policy Plan"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.47608","article-title":"Impact of silymarin supplements on liver enzyme levels: a systematic review","volume":"15","author":"Calderon Martinez E","year":"2023","unstructured":"Calderon Martinez E, Herrera D, Mogan S, et al.. Impact of silymarin supplements on liver enzyme levels: a systematic review. Cureus. 2023, 15:e47608. 10.7759\/cureus.47608","journal-title":"Cureus"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.17226\/24624","article-title":"Communities in Action - Pathways to Health Equity","author":"National Academies of Sciences","year":"2017","unstructured":"National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on Community-Based Solutions to Promote Health Equity in the United States. Communities in Action - Pathways to Health Equity. Baciu A, Negussie Y, Geller A, Weinstein JN (ed): National Academies Press (US), Washington, DC; 2017. 10.17226\/24624"},{"key":"ref30","article-title":"Improving Diagnosis in Health Care","author":"Committee on Diagnostic Error in Health Care; Board on Health Care Services; Institute of Medicine; The National Academies of Sciences","year":"2015","unstructured":"Committee on Diagnostic Error in Health Care; Board on Health Care Services; Institute of Medicine; The National Academies of Sciences, Engineering, and Medicine. Improving Diagnosis in Health Care. Balogh EP, Miller BT, Ball JR (ed): National Academies Press (US), Washington, DC; 2015."},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(18)30386-3","article-title":"High-quality health systems in the Sustainable Development Goals era: time for a revolution","volume":"6","author":"Kruk ME","year":"2018","unstructured":"Kruk ME, Gage AD, Arsenault C, et al.. High-quality health systems in the Sustainable Development Goals era: time for a revolution. Lancet Glob Health. 2018, 6:e1196-252. 10.1016\/S2214-109X(18)30386-3","journal-title":"Lancet Glob Health"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/S11920-021-01274-4\/METRICS","article-title":"Disparities in health care and the digital divide","volume":"23","author":"Saeed SA","year":"2021","unstructured":"Saeed SA, Masters RMR. Disparities in health care and the digital divide. Curr Psychiatry Rep. 2021, 23:1-6. 10.1007\/S11920-021-01274-4\/METRICS","journal-title":"Curr Psychiatry Rep"},{"key":"ref33","unstructured":"WDI - classifying countries by income. (2024). Accessed. May 20, 2024: https:\/\/datatopics.worldbank.org\/world-development-indicators\/stories\/the-classification-of-countries-by-income.html."},{"key":"ref34","unstructured":"Gross national income per capita (Atlas method). (2024). Accessed. May 13, 2024: https:\/\/www.who.int\/data\/gho\/indicator-metadata-registry\/imr-details\/3355."},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.2012.04.110259","article-title":"A national survey of hemochromatosis patients","volume":"25","author":"Mainous AG 3rd","year":"2012","unstructured":"Mainous AG 3rd, Knoll ME, Everett CJ, et al.. A national survey of hemochromatosis patients. J Am Board Fam Med. 2012, 25:432-6. 10.3122\/jabfm.2012.04.110259","journal-title":"J Am Board Fam Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_529_19","article-title":"Common presentation of an uncommon anaemia in a resource-limited setting: a diagnostic challenge","volume":"8","author":"Roy S","year":"2019","unstructured":"Roy S, Pathania M, Kant R, Dhar M, Amisha, Malik P, Rathaur VK. Common presentation of an uncommon anaemia in a resource-limited setting: a diagnostic challenge. J Family Med Prim Care. 2019, 8:3766-8. 10.4103\/jfmpc.jfmpc_529_19","journal-title":"J Family Med Prim Care"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.46330","article-title":"Hypertrophic cardiomyopathy diagnosis and treatment in high- and low-income countries: a narrative review","volume":"15","author":"Calderon Martinez E","year":"2023","unstructured":"Calderon Martinez E, Ortiz-Garcia NY, Herrera Hernandez DA, et al.. Hypertrophic cardiomyopathy diagnosis and treatment in high- and low-income countries: a narrative review. Cureus. 2023, 15:e46330. 10.7759\/cureus.46330","journal-title":"Cureus"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.25959\/23239481.V1","article-title":"The Health Economics of Haemochromatosis","author":"de Graaff B","year":"2016","unstructured":"de Graaff B. The Health Economics of Haemochromatosis. University of Tasmania, Hobart, Australia; 2016. 10.25959\/23239481.V1"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2018170079","article-title":"Liver iron quantification with MR imaging: a primer for radiologists","volume":"38","author":"Labranche R","year":"2018","unstructured":"Labranche R, Gilbert G, Cerny M, et al.. Liver iron quantification with MR imaging: a primer for radiologists. Radiographics. 2018, 38:392-412. 10.1148\/rg.2018170079","journal-title":"Radiographics"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1159\/000444549","article-title":"Pathogenesis, diagnosis and treatment of hemochromatosis","volume":"34","author":"Zoller H","year":"2016","unstructured":"Zoller H, Henninger B. Pathogenesis, diagnosis and treatment of hemochromatosis. Dig Dis. 2016, 34:364-73. 10.1159\/000444549","journal-title":"Dig Dis"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.07.052","article-title":"Utility of serum biomarker indices for staging of hepatic fibrosis before and after venesection in patients with hemochromatosis caused by variants in HFE","volume":"19","author":"Chin J","year":"2021","unstructured":"Chin J, Powell LW, Ramm LE, Hartel GF, Olynyk JK, Ramm GA. Utility of serum biomarker indices for staging of hepatic fibrosis before and after venesection in patients with hemochromatosis caused by variants in HFE. Clin Gastroenterol Hepatol. 2021, 19:1459-68. 10.1016\/j.cgh.2020.07.052","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15739","article-title":"Comparative accuracy of ferritin, transferrin saturation and soluble transferrin receptor for the diagnosis of iron deficiency in inflammatory bowel disease","volume":"51","author":"Daude S","year":"2020","unstructured":"Daude S, Remen T, Chateau T, et al.. Comparative accuracy of ferritin, transferrin saturation and soluble transferrin receptor for the diagnosis of iron deficiency in inflammatory bowel disease. Aliment Pharmacol Ther. 2020, 51:1087-95. 10.1111\/apt.15739","journal-title":"Aliment Pharmacol Ther"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000002416","article-title":"Transferrin saturation as a surrogate marker for assessment of labile nontransferrin bound iron in chronic liver disease","volume":"34","author":"Oliveira PM","year":"2022","unstructured":"Oliveira PM, Esp\u00f3sito BP, Carvente C, Silva GA, Dellavance A, Baldo DC, Ferraz ML. Transferrin saturation as a surrogate marker for assessment of labile nontransferrin bound iron in chronic liver disease. Eur J Gastroenterol Hepatol. 2022, 34:1047-52. 10.1097\/MEG.0000000000002416","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref44","unstructured":"Transferrin from human serum. (2024). Accessed. May 13, 2024: https:\/\/www.sigmaaldrich.com\/AR\/es\/product\/roche\/10652202001."},{"key":"ref45","unstructured":"Serum transferrin saturation. (2024). Accessed. May 13, 2024: https:\/\/www.ganeshdiagnostic.com\/serum-transferrin-saturation-test."},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(97)80357-1","article-title":"Analysis of the cost of population screening for haemochromatosis using biochemical and genetic markers","volume":"27","author":"Bassett ML","year":"1997","unstructured":"Bassett ML, Leggett BA, Halliday JW, Webb S, Powell LW. Analysis of the cost of population screening for haemochromatosis using biochemical and genetic markers. J Hepatol. 1997, 27:517-24. 10.1016\/S0168-8278(97)80357-1","journal-title":"J Hepatol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-015-0189-y","article-title":"A systematic review and narrative synthesis of health economic studies conducted for hereditary haemochromatosis","volume":"13","author":"de Graaff B","year":"2015","unstructured":"de Graaff B, Neil A, Sanderson K, Si L, Yee KC, Palmer AJ. A systematic review and narrative synthesis of health economic studies conducted for hereditary haemochromatosis. Appl Health Econ Health Policy. 2015, 13:469-83. 10.1007\/s40258-015-0189-y","journal-title":"Appl Health Econ Health Policy"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.14740\/gr1206","article-title":"Diagnosis and treatment of genetic HFE-hemochromatosis: the Danish aspect","volume":"12","author":"Milman NT","year":"2019","unstructured":"Milman NT, Schioedt FV, Junker AE, Magnussen K. Diagnosis and treatment of genetic HFE-hemochromatosis: the Danish aspect. Gastroenterology Res. 2019, 12:221-32. 10.14740\/gr1206","journal-title":"Gastroenterology Res"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1007\/S10528-013-9593-X\/METRICS","article-title":"Design and validation of a colorimetric test for the genetic diagnosis of hemochromatosis using \u03b1-phosphorothioate nucleotides","volume":"51","author":"Brug\u00e8re JF","year":"2013","unstructured":"Brug\u00e8re JF, Gobron S, Baud E, Cailloux F. Design and validation of a colorimetric test for the genetic diagnosis of hemochromatosis using \u03b1-phosphorothioate nucleotides. Biochem Genet. 2013, 51:635-43. 10.1007\/S10528-013-9593-X\/METRICS","journal-title":"Biochem Genet"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2019.25.12.1377","article-title":"Health care utilization and economic burdens of hemochromatosis in the United States: a population-based claims study","volume":"25","author":"Elsaid MI","year":"2019","unstructured":"Elsaid MI, John T, Li Y, et al.. Health care utilization and economic burdens of hemochromatosis in the United States: a population-based claims study. J Manag Care Spec Pharm. 2019, 25:1377-86. 10.18553\/jmcp.2019.25.12.1377","journal-title":"J Manag Care Spec Pharm"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.2478\/JHP-2023-0011","article-title":"Access equity: key questions and challenges - a report from the 1st workshop of the European Haemophilia Consortium (EHC) Think Tank Workstream on Access Equity","volume":"10","author":"Skouw-Rasmussen N","year":"2023","unstructured":"Skouw-Rasmussen N, Savini L. Access equity: key questions and challenges - a report from the 1st workshop of the European Haemophilia Consortium (EHC) Think Tank Workstream on Access Equity. J Haemophilia Pract. 2023, 10:56-61. 10.2478\/JHP-2023-0011","journal-title":"J Haemophilia Pract"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.19080\/JOCCT.2023.18.555989","article-title":"An overview of the identification, prevention, and management of immunological reactions to blood transfusion","volume":"18","author":"Aggarwal P","year":"2023","unstructured":"Aggarwal P, Calderon Martinez E, Quijano BEA, et al.. An overview of the identification, prevention, and management of immunological reactions to blood transfusion. J Cardiol Cardiovasc Ther. 2023, 18:24-6. 10.19080\/JOCCT.2023.18.555989","journal-title":"J Cardiol Cardiovasc Ther"},{"key":"ref53","article-title":"Searching for hereditary hemochromatosis","volume":"19","author":"Laudicina RJ","year":"2006","unstructured":"Laudicina RJ. Searching for hereditary hemochromatosis. Clin Lab Sci. 2006, 19:174-83.","journal-title":"Clin Lab Sci"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1136\/GUTJNL-2023-BASL.112CORR1","article-title":"P97 A patient information bundle outlining dietary advice in liver disease specific to the cost of living crisis improves patient care: \u2018Looking after Your Liver for Less.\u2019","volume":"73","author":"Lagnado A","year":"2024","unstructured":"Lagnado A, Taylor O, Hayes B, Tilden S, Phillips J, Lagnado A, Abeysekera K. P97 A patient information bundle outlining dietary advice in liver disease specific to the cost of living crisis improves patient care: \u2018Looking after Your Liver for Less.\u2019. Gut. 2024, 73:63-5. 10.1136\/GUTJNL-2023-BASL.112CORR1","journal-title":"Gut"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-1742547\/v1","article-title":"Underdiagnosis of hereditary haemochromatosis; a retrospective study of 362,275 patients","volume":"4","author":"Krasin E","year":"2022","unstructured":"Krasin E, Doron R, Morgan S, Schermann H. Underdiagnosis of hereditary haemochromatosis; a retrospective study of 362,275 patients. ResSquare. 2022, 4:24-6. 10.21203\/rs.3.rs-1742547\/v1","journal-title":"ResSquare"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.14740\/gr.v16i2.1632","article-title":"Correction to: Diagnosis and treatment of genetic HFE-hemochromatosis: the Danish aspect","volume":"16","author":"Milman NT","year":"2023","unstructured":"Milman NT, Milman NT, Schiodt FV, Junker AE, Magnussen K. Correction to: Diagnosis and treatment of genetic HFE-hemochromatosis: the Danish aspect. Gastroenterology Res. 2023, 16:125. 10.14740\/gr.v16i2.1632","journal-title":"Gastroenterology Res"},{"key":"ref57","unstructured":"Biopsychosocial correlates in 21st century medical education. from theory to practice. (2024). Accessed: June 7, 2024: https:\/\/www.researchgate.net\/publication\/376796458_Correlatos_Biopsicosociales_En_La_Educacion_Medica_Del_Siglo_XXI_D...."},{"key":"ref58","unstructured":"WDI - classifying countries by income. (2024). Accessed. June 12, 2024: https:\/\/datatopics.worldbank.org\/world-development-indicators\/stories\/the-classification-of-countries-by-income.html."},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1111\/vox.12896","article-title":"Diagnosis and management of hereditary haemochromatosis","volume":"115","author":"Murphree CR","year":"2020","unstructured":"Murphree CR, Nguyen NN, Raghunathan V, Olson SR, DeLoughery T, Shatzel JJ. Diagnosis and management of hereditary haemochromatosis. Vox Sang. 2020, 115:255-62. 10.1111\/vox.12896","journal-title":"Vox Sang"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(17)30214-4","article-title":"Reduction of body iron in HFE-related haemochromatosis and moderate iron overload (Mi-Iron): a multicentre, participant-blinded, randomised controlled trial","volume":"4","author":"Ong SY","year":"2017","unstructured":"Ong SY, Gurrin LC, Dolling L, et al.. Reduction of body iron in HFE-related haemochromatosis and moderate iron overload (Mi-Iron): a multicentre, participant-blinded, randomised controlled trial. Lancet Haematol. 2017, 4:e607-14. 10.1016\/S2352-3026(17)30214-4","journal-title":"Lancet Haematol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15436-6","article-title":"Non-invasive assessment of hepatic iron stores by MRI","volume":"363","author":"Gandon Y","year":"2004","unstructured":"Gandon Y, Olivi\u00e9 D, Guyader D, Aub\u00e9 C, Oberti F, Sebille V, Deugnier Y. Non-invasive assessment of hepatic iron stores by MRI. Lancet. 2004, 363:357-62. 10.1016\/S0140-6736(04)15436-6","journal-title":"Lancet"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12762","article-title":"Non-invasive assessment of liver fibrosis in C282Y homozygous HFE hemochromatosis","volume":"35","author":"Legros L","year":"2015","unstructured":"Legros L, Bardou-Jacquet E, Latournerie M, et al.. Non-invasive assessment of liver fibrosis in C282Y homozygous HFE hemochromatosis. Liver Int. 2015, 35:1731-8. 10.1111\/liv.12762","journal-title":"Liver Int"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/J.RARD.2016.06.005","article-title":"Ultrasound first: Why, how and when? (Article in Spanish)","volume":"81","author":"Poggio GA","year":"2017","unstructured":"Poggio GA, Mariano J, Gopar LA, Ucar ME. Ultrasound first: Why, how and when? (Article in Spanish). Rev Argentina de Radiol. 2017, 81:192-203. 10.1016\/J.RARD.2016.06.005","journal-title":"Rev Argentina de Radiol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.5811\/westjem.2016.8.31387","article-title":"Pilot point-of-care ultrasound curriculum at Harvard Medical School: early experience","volume":"17","author":"Rempell JS","year":"2016","unstructured":"Rempell JS, Saldana F, DiSalvo D, et al.. Pilot point-of-care ultrasound curriculum at Harvard Medical School: early experience. West J Emerg Med. 2016, 17:734-40. 10.5811\/westjem.2016.8.31387","journal-title":"West J Emerg Med"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.33588\/FEM.263.1279","article-title":"Reflections on the design of an ultrasound study program in medical undergraduate","volume":"26","author":"Calder\u00f3n-Mart\u00ednez E","year":"2023","unstructured":"Calder\u00f3n-Mart\u00ednez E, Pe\u00f1a-Carranza R, Sampieri-Cabrera R. Reflections on the design of an ultrasound study program in medical undergraduate. Rev de la Fundaci\u00f3n Edu M\u00e9d. 2023, 26:93-9. 10.33588\/FEM.263.1279","journal-title":"Rev de la Fundaci\u00f3n Edu M\u00e9d"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1109\/EMBC.2014.6944779","article-title":"Estimation of liver iron concentration by dual energy CT images: influence of X-ray energy on sensitivity","volume":"2014","author":"Malvarosa I","year":"2014","unstructured":"Malvarosa I, Massaroni C, Liguori C, et al.. Estimation of liver iron concentration by dual energy CT images: influence of X-ray energy on sensitivity. Annu Int Conf IEEE Eng Med Biol Soc. 2014, 2014:5129-32. 10.1109\/EMBC.2014.6944779","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(89)90646-x","article-title":"Evaluation of computed tomography in the assessment of liver iron overload. A study of 46 cases of idiopathic hemochromatosis","volume":"97","author":"Guyader D","year":"1989","unstructured":"Guyader D, Gandon Y, Deugnier Y, et al.. Evaluation of computed tomography in the assessment of liver iron overload. A study of 46 cases of idiopathic hemochromatosis. Gastroenterology. 1989, 97:737-43. 10.1016\/0016-5085(89)90646-x","journal-title":"Gastroenterology"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2422052024","article-title":"Liver fat: effect of hepatic iron deposition on evaluation with opposed-phase MR imaging","volume":"242","author":"Westphalen AC","year":"2007","unstructured":"Westphalen AC, Qayyum A, Yeh BM, et al.. Liver fat: effect of hepatic iron deposition on evaluation with opposed-phase MR imaging. Radiology. 2007, 242:450-5. 10.1148\/radiol.2422052024","journal-title":"Radiology"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1345.046","article-title":"Measurement and mapping of liver iron concentrations using magnetic resonance imaging","volume":"1054","author":"St Pierre TG","year":"2005","unstructured":"St Pierre TG, Clark PR, Chua-Anusorn W. Measurement and mapping of liver iron concentrations using magnetic resonance imaging. Ann N Y Acad Sci. 2005, 1054:379-85. 10.1196\/annals.1345.046","journal-title":"Ann N Y Acad Sci"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.193.2.7972774","article-title":"Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo MR imaging","volume":"193","author":"Gandon Y","year":"1994","unstructured":"Gandon Y, Guyader D, Heautot JF, et al.. Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo MR imaging. Radiology. 1994, 193:533-8. 10.1148\/radiology.193.2.7972774","journal-title":"Radiology"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2017.10.008","article-title":"MRI for the measurement of liver iron content, and for the diagnosis and follow-up of iron overload disorders","volume":"46","author":"Paisant A","year":"2017","unstructured":"Paisant A, d'Assignies G, Bannier E, Bardou-Jacquet E, Gandon Y. MRI for the measurement of liver iron content, and for the diagnosis and follow-up of iron overload disorders. Presse Med. 2017, 46:e279-87. 10.1016\/j.lpm.2017.10.008","journal-title":"Presse Med"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1111\/hex.13830","article-title":"Haemochromatosis patients' research priorities: towards an improved quality of life","volume":"26","author":"Romero-Cortadellas L","year":"2023","unstructured":"Romero-Cortadellas L, Venturi V, Mart\u00edn-S\u00e1nchez JC, et al.. Haemochromatosis patients' research priorities: towards an improved quality of life. Health Expect. 2023, 26:2293-301. 10.1111\/hex.13830","journal-title":"Health Expect"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPMPSINQ9BRMU6","article-title":"Laboratory systems and services are critical in global health: time to end the neglect?","volume":"134","author":"Nkengasong JN","year":"2010","unstructured":"Nkengasong JN, Nsubuga P, Nwanyanwu O, et al.. Laboratory systems and services are critical in global health: time to end the neglect?. Am J Clin Pathol. 2010, 134:368-73. 10.1309\/AJCPMPSINQ9BRMU6","journal-title":"Am J Clin Pathol"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30308-8","article-title":"Laboratory medicine in low-income and middle-income countries: progress and challenges","volume":"391","author":"Nkengasong JN","year":"2018","unstructured":"Nkengasong JN, Yao K, Onyebujoh P. Laboratory medicine in low-income and middle-income countries: progress and challenges. Lancet. 2018, 391:1873-5. 10.1016\/S0140-6736(18)30308-8","journal-title":"Lancet"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-145-3-200608010-00009","article-title":"Screening for hereditary hemochromatosis: a systematic review for the U.S. Preventive Services Task Force","volume":"145","author":"Whitlock EP","year":"2006","unstructured":"Whitlock EP, Garlitz BA, Harris EL, Beil TL, Smith PR. Screening for hereditary hemochromatosis: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2006, 145:209-23. 10.7326\/0003-4819-145-3-200608010-00009","journal-title":"Ann Intern Med"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12347","article-title":"Epidemiology and diagnostic testing for hemochromatosis and iron overload","volume":"37","author":"Adams PC","year":"2015","unstructured":"Adams PC. Epidemiology and diagnostic testing for hemochromatosis and iron overload. Int J Lab Hematol. 2015, 37:25-30. 10.1111\/ijlh.12347","journal-title":"Int J Lab Hematol"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1186\/1478-4491-5-8","article-title":"Public-private partnerships to build human capacity in low income countries: findings from the Pfizer program","volume":"5","author":"Vian T","year":"2007","unstructured":"Vian T, Richards SC, McCoy K, Connelly P, Feeley F. Public-private partnerships to build human capacity in low income countries: findings from the Pfizer program. Hum Resour Health. 2007, 5:8. 10.1186\/1478-4491-5-8","journal-title":"Hum Resour Health"},{"key":"ref78","unstructured":"CDC archive. FETP - Field Epidemiology Training Program - disease detectives in action. (2024). Accessed: June 6, 2024: https:\/\/archive.cdc.gov\/."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/268573-the-genetic-diagnostics-of-hemochromatosis-disparities-in-low--versus-high-income-countries","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T12:31:00Z","timestamp":1720441860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/268573-the-genetic-diagnostics-of-hemochromatosis-disparities-in-low--versus-high-income-countries"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,8]]},"references-count":78,"URL":"https:\/\/doi.org\/10.7759\/cureus.64074","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,8]]}}}